Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system

Abstract Microglia/macrophages participate in the development of and recovery from experimental autoimmune encephalomyelitis (EAE), and the macrophage M1 (pro-inflammatory)/M2 (anti-inflammatory) phase transition is involved in EAE disease progression. We evaluated the efficacy of crisdesalazine (a...

Full description

Saved in:
Bibliographic Details
Main Authors: Su-Min Park, Yong-Hun Oh, Ga-Hyun Lim, Ju-Hyun An, Jin-Hwan Lee, Byoung-Joo Gwag, So-Jung Won, Kyoung-Won Seo, Hwa-Young Youn
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Neuroscience
Subjects:
Online Access:https://doi.org/10.1186/s12868-024-00920-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559852396052480
author Su-Min Park
Yong-Hun Oh
Ga-Hyun Lim
Ju-Hyun An
Jin-Hwan Lee
Byoung-Joo Gwag
So-Jung Won
Kyoung-Won Seo
Hwa-Young Youn
author_facet Su-Min Park
Yong-Hun Oh
Ga-Hyun Lim
Ju-Hyun An
Jin-Hwan Lee
Byoung-Joo Gwag
So-Jung Won
Kyoung-Won Seo
Hwa-Young Youn
author_sort Su-Min Park
collection DOAJ
description Abstract Microglia/macrophages participate in the development of and recovery from experimental autoimmune encephalomyelitis (EAE), and the macrophage M1 (pro-inflammatory)/M2 (anti-inflammatory) phase transition is involved in EAE disease progression. We evaluated the efficacy of crisdesalazine (a novel microsomal prostaglandin E2 synthase-1 inhibitor) in an EAE model, including its immune-regulating potency in lipopolysaccharide-stimulated macrophages, and its neuroprotective effects in a macrophage-neuronal co-culture system. Crisdesalazine significantly alleviated clinical symptoms, inhibited inflammatory cell infiltration and demyelination in the spinal cord, and altered the phase of microglial/macrophage and regulatory T cells. Crisdesalazine promoted the M1 to M2 phase transition in macrophages (immunomodulation) and reduced neuronal necrosis (neuroprotection) in vitro. This is the first study to directly demonstrate the therapeutic effects of a microsomal prostaglandin E2 synthase-1 inhibitor in an EAE model and its ability to alter macrophage polarization, suggesting that it may be a new therapeutic option for the treatment of patients affected by multiple sclerosis and other autoimmune diseases.
format Article
id doaj-art-f5ee6b71d3ea4e3ebe8c608bd053575d
institution Kabale University
issn 1471-2202
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Neuroscience
spelling doaj-art-f5ee6b71d3ea4e3ebe8c608bd053575d2025-01-05T12:09:38ZengBMCBMC Neuroscience1471-22022025-01-0126111310.1186/s12868-024-00920-wCrisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune systemSu-Min Park0Yong-Hun Oh1Ga-Hyun Lim2Ju-Hyun An3Jin-Hwan LeeByoung-Joo Gwag4So-Jung Won5Kyoung-Won Seo6Hwa-Young Youn7Laboratory of Veterinary Internal Medicine, Department of Clinical Veterinary Science, College of Veterinary Medicine, Seoul National UniversityLaboratory of Veterinary Internal Medicine, Department of Clinical Veterinary Science, College of Veterinary Medicine, Seoul National UniversityLaboratory of Veterinary Internal Medicine, Department of Clinical Veterinary Science, College of Veterinary Medicine, Seoul National UniversityDepartment of Veterinary Emergency and Critical Care Medicine and Institute of Veterinary Science, College of Veterinary Medicine, Kangwon National UniversityGNT Pharma Co. Ltd.GNT Pharma Co. Ltd.Laboratory of Veterinary Internal Medicine, Department of Clinical Veterinary Science, College of Veterinary Medicine, Seoul National UniversityLaboratory of Veterinary Internal Medicine, Department of Clinical Veterinary Science, College of Veterinary Medicine, Seoul National UniversityAbstract Microglia/macrophages participate in the development of and recovery from experimental autoimmune encephalomyelitis (EAE), and the macrophage M1 (pro-inflammatory)/M2 (anti-inflammatory) phase transition is involved in EAE disease progression. We evaluated the efficacy of crisdesalazine (a novel microsomal prostaglandin E2 synthase-1 inhibitor) in an EAE model, including its immune-regulating potency in lipopolysaccharide-stimulated macrophages, and its neuroprotective effects in a macrophage-neuronal co-culture system. Crisdesalazine significantly alleviated clinical symptoms, inhibited inflammatory cell infiltration and demyelination in the spinal cord, and altered the phase of microglial/macrophage and regulatory T cells. Crisdesalazine promoted the M1 to M2 phase transition in macrophages (immunomodulation) and reduced neuronal necrosis (neuroprotection) in vitro. This is the first study to directly demonstrate the therapeutic effects of a microsomal prostaglandin E2 synthase-1 inhibitor in an EAE model and its ability to alter macrophage polarization, suggesting that it may be a new therapeutic option for the treatment of patients affected by multiple sclerosis and other autoimmune diseases.https://doi.org/10.1186/s12868-024-00920-wAnti-inflammationCrisdesalazineExperimental autoimmune encephalomyelitisMicrosomal prostaglandin E2 synthase-1Macrophage
spellingShingle Su-Min Park
Yong-Hun Oh
Ga-Hyun Lim
Ju-Hyun An
Jin-Hwan Lee
Byoung-Joo Gwag
So-Jung Won
Kyoung-Won Seo
Hwa-Young Youn
Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system
BMC Neuroscience
Anti-inflammation
Crisdesalazine
Experimental autoimmune encephalomyelitis
Microsomal prostaglandin E2 synthase-1
Macrophage
title Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system
title_full Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system
title_fullStr Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system
title_full_unstemmed Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system
title_short Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system
title_sort crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune system
topic Anti-inflammation
Crisdesalazine
Experimental autoimmune encephalomyelitis
Microsomal prostaglandin E2 synthase-1
Macrophage
url https://doi.org/10.1186/s12868-024-00920-w
work_keys_str_mv AT suminpark crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT yonghunoh crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT gahyunlim crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT juhyunan crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT jinhwanlee crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT byoungjoogwag crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT sojungwon crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT kyoungwonseo crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem
AT hwayoungyoun crisdesalazinealleviatesinflammationinanexperimentalautoimmuneencephalomyelitismultiplesclerosismousemodelbyregulatingtheimmunesystem